Telithromycin

This classification denotes a macrolide antibiotic with the molecular formula C43H65N5O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KI8H7H19WL, chemically known as erythromycin, 3-de((2,6-dideoxy-3-c-methyl-3-o-methyl-alpha-l-ribo-hexopyranosyl)oxy)-11,12-dideoxy-6-o-methyl-3-oxo-12,11-(oxycarbonyl((4-(4-(3-pyridinyl)-1h-imidazol-1-yl)butyl)imino))- but generally known as telithromycin, which bears US NIH Compound Identifier 3002190. European Medicines Agency schedules Telithromycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12606MIG. The term TELITHROMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 3, 1999, List 42). World Health Organization schedules telithromycin in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule telithromycin under HS 29419000 and SITC 54139. As of Q4 2014, TELITHROMYCIN remains the US FDA Preferred Term for this commodity. Telithromycin bears US NLM identifiers UMLS ID C1452484 and NCI Concept Code C61963. SMILES: O1C2(C(N(C1=O)CCCCN1CC(NC1)C1CCCNC1)C(C(=O)C(CC(OC)(C(OC1OC(CC(N(C)C)C1O)C)C(C(=O)C(C(=O)OC2CC)C)C)C)C)C)C.